LyndaASzczechMD

Vice President of Clinical Development, Fibrogen, San Francisco CA

Dr. Szczech is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

7 citations
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.
Pablo E Pergola, Chaim Charytan, Dustin J Little, Stefan Tham, Lynda Szczech
Kidney360. 2022-09-29
Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.". 2021;6:613-623.
Robert Provenzano, Steven Fishbane, Lynda Szczech, Robert Leong, Khalil G Saikali
Kidney International Reports. 2022-03-01
80 citations
Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
Robert Provenzano, Evgeny Shutov, Liubov Eremeeva, Svitlana Korneyeva, Lona Poole
Nephrology, Dialysis, Transplantation. 2021-08-27

Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 StudyFebruary 11th, 2021

Analysis Of Associations Between Anemia Correction In CKD And MORTALITY: ChoirNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
An Observational Study Of The Pharmacokinetics Of Efavirenz, Nevirapine, And LOPNational Center For Research Resources2005
Epidemiology And Clinical Course Of HIV NephropathyNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004